Chris Nasveschuk
Senior Vice-President of Chemical Sciences C4 Therapeutics Inc
Seminars
Wednesday 29th October 2025
Advancing CNS Penetrant Degraders Through Emerging Design Principles to Cross the BBB
1:30 pm
Download the Full Event Guide for Full Session Details.
- What does the literature teach us about CNS drugs, including beyond rule of 5 drugs, with CNS exposure?
- Current methods for CNS exposure and Kpuu determination
- Heterobifunctional degraders that demonstrate CNS exposure
